Tumor angiogenesis inhibitors

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Tumor angiogenesis is crucial for neoplasm malignant transformation, enabling tumor cell invasion and metastasis.
• Understanding tumor angiogenesis mechanisms has led to novel anti-cancer therapies targeting angiogenesis inhibitors.
• Endogenous and synthetic angiogenesis inhibitors offer potential for cancer treatment.

Purpose of the Study:

• To review the mechanisms of action and expression of major endogenous inhibitors of tumor and physiological angiogenesis.
• To analyze the antiangiogenic effects of synthetic inhibitors in relation to tumor angiogenesis.
• To discuss the potential applications of antiangiogenic therapy in cancer chemotherapy.

Main Methods:

• Literature review of endogenous and synthetic angiogenesis inhibitors.
• Analysis of molecular mechanisms regulating tumor angiogenesis.
• Evaluation of antiangiogenic effects and therapeutic potential.

Main Results:

• Identified key endogenous molecules regulating both physiological and tumor angiogenesis.
• Detailed the mechanisms of action for various synthetic angiogenesis inhibitors.
• Highlighted the role of these inhibitors in blocking critical steps of tumor angiogenesis.

Conclusions:

• Targeting tumor angiogenesis with inhibitors is a promising therapeutic strategy.
• Further research into endogenous and synthetic inhibitors can enhance cancer chemotherapy.
• Antiangiogenic therapy holds significant potential for improving cancer treatment outcomes.